Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics

This collaboration will harness Charles River's expertise in plasmid DNA production to support Axovia Therapeutics' mission of developing potentially transformative therapies for ciliopathies. Axovia believe this partnership will play a crucial role in accelerating our efforts to bring impactful therapies to patients in need.